期刊文献+
共找到699篇文章
< 1 2 35 >
每页显示 20 50 100
ER、PR、HER-2及Ki-67表达与乳腺癌患者新辅助化疗后病理完全缓解的相关性分析
1
作者 宋莹 李江龙 《中国医学创新》 CAS 2024年第27期139-143,共5页
目的:分析雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)、人表皮生长因子受体-2(human epidermal growth factor receptor-2,HER-2)及Ki67抗原(Ki-67)表达与乳腺癌患者新辅助化疗后病理完全缓解(pathologic... 目的:分析雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)、人表皮生长因子受体-2(human epidermal growth factor receptor-2,HER-2)及Ki67抗原(Ki-67)表达与乳腺癌患者新辅助化疗后病理完全缓解(pathologic complete response,pCR)的相关性。方法:回顾性分析2022年1月—2023年12月在江西省肿瘤医院行新辅助化疗的200例乳腺癌患者的临床资料,根据化疗后手术病理标本,分为pCR组68例和非pCR组132例,比较两组临床资料和ER、PR、HER-2及Ki-67表达,多因素logistic回归分析ER、PR、HER-2及Ki-67表达与pCR的相关性。结果:单因素分析显示,pCR组临床分期Ⅱ期比例高于非pCR组,ER、PR阴性比例均高于非pCR组,HER-2阳性比例高于非pCR组,Ki-67≥20%比例高于非pCR组,差异均有统计学意义(P<0.05)。多因素logistic回归分析显示,临床分期Ⅲ期、ER阳性、PR阳性、HER-2阴性、Ki-67<20%是乳腺癌新辅助化疗后pCR的危险因素(P<0.05)。结论:ER、PR、HER-2及Ki-67表达是乳腺癌患者新辅助化疗后pCR的影响因素,可为临床治疗提供依据。 展开更多
关键词 乳腺癌 雌激素受体 孕激素受体 人表皮生长因子受体-2 KI67抗原 新辅助化疗 病理完全缓解
下载PDF
T1期乳腺癌超声特征与ER、PR、HER-2、Ki-67表达的相关性分析
2
作者 魏伟 徐静雅 +4 位作者 冯慧俊 张霞 武静 张伟 江峰 《大理大学学报》 2024年第2期55-62,共8页
目的:探讨T1期乳腺癌超声声像图特征与雌激素受体(ER)、孕激素受体(PR)、人类表皮生长因子受体2(HER-2)、细胞增殖相关抗原Ki-67表达的相关性。方法:回顾性收集2012年1月至2021年6月经病理证实为单发乳腺恶性肿瘤患者493例的病历资料,... 目的:探讨T1期乳腺癌超声声像图特征与雌激素受体(ER)、孕激素受体(PR)、人类表皮生长因子受体2(HER-2)、细胞增殖相关抗原Ki-67表达的相关性。方法:回顾性收集2012年1月至2021年6月经病理证实为单发乳腺恶性肿瘤患者493例的病历资料,记录超声特征及免疫组化结果,并对二者进行相关性分析。结果:ER、PR、HER-2、Ki-67阳性率分别为78.09%、67.34%、21.10%、71.60%;ER与PR表达呈正相关,HER-2与ER、PR表达呈负相关;Ki-67与HER-2表达呈正相关,与ER、PR表达呈负相关。ER阳性表达与形态不规则、边缘不规整、间质脂肪侵犯、有高回声晕等超声特征有关,PR阳性表达与病灶内部成分、腋窝淋巴结转移等超声特征有关,Ki-67阳性表达与边界不清晰、间质脂肪侵犯、有高回声晕等超声特征有关,差异均有统计学意义(P<0.05)。结论:T1期乳腺癌的超声征象与ER、PR、Ki-67表达存在一定的相关性,超声声像图的变化可以提示肿瘤生物学行为,为医生临床决策提供参考。 展开更多
关键词 T1期乳腺癌 超声特征 雌激素受体 孕激素受体 人类表皮生长因子
下载PDF
NDRG2调控IRE1α-XBP1介导内质网应激逆转ER+乳腺癌他莫昔芬耐药
3
作者 王守莹 杜彦艳 +5 位作者 曹鹏 刘文宇 齐俊愉 石炜业 张春晓 周晓雷 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2024年第10期1409-1416,共8页
他莫昔芬(tamoxifen,TAM)作为雌激素受体阳性(estrogen receptor,ER+)乳腺癌的一线化疗药物使大多数患者受益,但原发性和继发性耐药问题严重影响临床治疗效果。深入研究ER+乳腺癌TAM耐药机制,改善治疗效果是当前亟待解决的问题。抑癌因... 他莫昔芬(tamoxifen,TAM)作为雌激素受体阳性(estrogen receptor,ER+)乳腺癌的一线化疗药物使大多数患者受益,但原发性和继发性耐药问题严重影响临床治疗效果。深入研究ER+乳腺癌TAM耐药机制,改善治疗效果是当前亟待解决的问题。抑癌因子NDRG2(N-myc downstream regulated gene 2,NDRG2)在肿瘤发生发展中发挥重要作用,但是否参与ER+乳腺癌TAM耐药尚不清楚。本研究旨在探明NDRG2在ER+乳腺癌TAM耐药中发挥的作用和机制。通过RT-PCR与免疫印迹分析对比TAM敏感型和耐药型ER+乳腺癌细胞发现,NDRG 2的mRNA转录水平和蛋白质翻译水平在TAM耐药细胞中表达显著下调,且与耐药能力负相关(P<0.001);CCK-8细胞毒性实验和软琼脂克隆形成实验证实,在耐药细胞中过表达NDRG2可显著降低TAM药物半抑制浓度IC 50和软琼脂克隆形成率(P<0.001),逆转耐药表型。分子机制上,X-box结合蛋白1(X-box binding protein 1,XBP1)mRNA剪切实验与内质网相关降解(endoplasmic-reticulum associated degradation,ERAD)报告蛋白的结果显示,过表达NDRG2可增强耐药细胞中剪切型XBP1s mRNA转录与ERAD报告蛋白CD3ε-YFP表达(P<0.001),引发耐药细胞内质网强应激反应;免疫印迹检测结果显示,过表达NDRG2可显著提高耐药细胞中内质网应激感受器肌醇需要激酶1α(inositol requiring enzyme 1,IRE1α)的磷酸化水平及其下游因子,例如内质网EIP辅助因子(endoplasmic reticulum-localized DnaJ 4,ERdj4)、PKR蛋白激酶的细胞抑制剂(cellular Inhibitor of the PKR protein kinase,P58 IPK)、α甘露糖苷酶样应激蛋白(er degradation enhancingαmannosidase likeprotein,EDEM)和蛋白质二硫键异构酶家族A成员5(protein disulfide isomerase family a member 5,PDIA5)的表达水平(P<0.001)。小鼠异种移植瘤研究进一步证实,在耐药细胞中过表达NDRG2可增强TAM治疗效果,显著抑制耐药移植瘤生长(P<0.001)。以上研究结果表明,通过提高耐药细胞中NDRG2表达,增强TAM治疗引发的内质网强烈应激,可逆转ER+乳腺癌细胞耐药性,改善TAM治疗效果。研究结果为解决ER+乳腺癌TAM耐药问题提供了新的思路和有价值的潜在药物靶点。 展开更多
关键词 雌激素受体阳性乳腺癌 N-myc下游调节基因2 他莫昔芬 耐药 内质网应激
下载PDF
宫颈癌组织中CSRP2BP mRNA,ESRRB mRNA和蛋白水平表达与上皮间质转化及临床预后相关性研究
4
作者 赵建芳 石芳 +1 位作者 张昕 贺薇冉 《现代检验医学杂志》 CAS 2024年第6期96-101,107,共7页
目的研究宫颈癌组织中富含半胱氨酸蛋白2结合蛋白(cysteine rich protein 2 binding protein,CSRP2BP)mRNA,雌激素相关受体β(estrogen related receptorsβ,ERRB)mRNA和蛋白表达与上皮间质转化(epithelial mesenchymal transition,EMT... 目的研究宫颈癌组织中富含半胱氨酸蛋白2结合蛋白(cysteine rich protein 2 binding protein,CSRP2BP)mRNA,雌激素相关受体β(estrogen related receptorsβ,ERRB)mRNA和蛋白表达与上皮间质转化(epithelial mesenchymal transition,EMT)及临床预后的相关性。方法选择2018年3月~2020年3月延安市中医医院收治的106例宫颈癌患者。采用实时荧光定量PCR(RT-qPCR)检测组织中CSRP2BP mRNA,ESRRB mRNA及EMT相关指标[E-钙黏蛋白(E-cadherin,E-cad),N-钙黏蛋白(N-cadherin,N-cad),锌指转录因子(Snail family transcriptional repressor,Snail)]表达。采用免疫组织化学检测组织中CSRP2BP蛋白,ESRRB蛋白表达。Pearson相关分析CSRP2BP mRNA,ESRRB mRNA与EMT相关指标的相关性。采用Kaplan-Meier曲线和COX回归分析CSRP2BP mRNA,ESRRB mRNA表达对宫颈癌患者预后的影响。结果癌组织中CSRP2BP mRNA(3.14±0.52 vs 1.22±0.21)和蛋白阳性率(86.79%vs 9.43%),ESRRB mRNA(2.86±0.31 vs 1.06±0.20)和蛋白阳性率(92.45%vs 8.49%),N-cad mRNA(3.22±0.43vs 1.05±0.26),Snail mRNA(2.67±0.36 vs 0.69±0.17)表达高于癌旁组织,E-cad mRNA(0.84±0.17 vs 2.15±0.24)表达低于癌旁组织,差异具有统计学意义(t/χ^(2)=34.249,127.049;50.234,149.466;44.461,51.204,45.858,均P<0.001)。宫颈癌中CSRP2BP mRNA,ESRRB mRNA与N-cad mRNA,Snail mRNA呈正相关(r=0.663,0.731;0.726,0.715,均P<0.001),与E-cad mRNA呈负相关(r=-0.594,-0.669,均P<0.001)。FIGO分期ⅠB2~ⅡA,低分化程度及淋巴结转移宫颈癌患者癌组织中CSRP2BP mRNA(4.24±0.57,4.27±0.58,4.24±0.50),ESRRB mRNA(4.48±0.36,4.21±0.37,4.69±0.33)高于FIGO分期ⅠA~ⅠB1(2.60±0.44,2.06±0.24),中高分化程度(2.43±0.44,2.01±0.25)及无淋巴结转移(2.53±0.58,2.07±0.26)的患者,差异具有统计学意义(t=16.327,41.135;18.507,36.545;14.501,43.806,均P<0.001)。CSRP2BP mRNA高表达三年总生存率为66.00%(33/50),低于低表达组的89.29%(50/56);ESRRB mRNA高表达组三年总生存率为65.38%(34/52),低于低表达组的90.74%(49/54),差异具有统计学意义(Log-rankχ^(2)=5.401,11.400,P=0.020,0.001)。多因素Cox回归分析显示,CSRP2BP mRNA高表达(HR=1.327,95%CI:1.0970~1.605)、ESRRB mRNA高表达(HR=1.322,95%CI:1.108~1.577)、FIGO分期ⅠB2~ⅡA期(HR=1.423,95%CI:1.154~1.755)、淋巴结转移(HR=1.363,95%CI:1.095~1.698)、低分化程度(HR=1.297,95%CI:1.064~1.581)是影响宫颈癌患者预后的危险因素(均P<0.001)。结论宫颈癌患者CSRP2BP mRNA,ESRRB mRNA表达升高,两者与EMT相关指标及不良临床病理特征有关,是新的预后评估的肿瘤标志物。 展开更多
关键词 宫颈癌 富含半胱氨酸的蛋白质2 雌激素相关受体β 上皮间质转化
下载PDF
Clinicopathological Features and Long-Term Prognostic Role of Human Epidermal Growth Factor Receptor-2 Low Expression in Chinese Patients with Early Breast Cancer:A Single-Institution Study
5
作者 KONG Zi Qing LIU Li Qun +11 位作者 HUANG De Qin WANG Yu Tong LI Jing Jie ZHANG Zheng WANG Xi Xi LIU Chuan Ling ZHANG Ya Di SHAO Jia Kang ZHU Yi Min CHEN Yi Meng LIU Mei ZHAO Wei Hong 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2024年第5期457-470,共14页
Objective This study aimed to comprehensively analyze and compare the clinicopathological features and prognosis of Chinese patients with human epidermal growth factor receptor 2(HER2)-low early breast cancer(BC)and H... Objective This study aimed to comprehensively analyze and compare the clinicopathological features and prognosis of Chinese patients with human epidermal growth factor receptor 2(HER2)-low early breast cancer(BC)and HER2-IHC0 BC.Methods Patients diagnosed with HER2-negative BC(N=999)at our institution between January2011 and December 2015 formed our study population.Clinicopathological characteristics,association between estrogen receptor(ER)expression and HER2-low,and evolution of HER2 immunohistochemical(IHC)score were assessed.Kaplan-Meier method and log-rank test were used to compare the long-term survival outcomes(5-year follow-up)between the HER2-IHC0 and HER2-low groups.Results HER2-low BC group tended to demonstrate high expression of ER and more progesterone receptor(PgR)positivity than HER2-IHC0 BC group(P<0.001).The rate of HER2-low status increased with increasing ER expression levels(Mantel-Haenszelχ^(2)test,P<0.001,Pearson’s R=0.159,P<0.001).Survival analysis revealed a significantly longer overall survival(OS)in HER2-low BC group than in HER2-IHC0 group(P=0.007)in the whole cohort and the hormone receptor(HR)-negative group.There were no significant differences between the two groups in terms of disease-free survival(DFS).The discordance rate of HER2 IHC scores between primary and metastatic sites was 36.84%.Conclusion HER2-low BC may not be regarded as a unique BC group in this population-based study due to similar clinicopathological features and prognostic roles. 展开更多
关键词 HER2 HER2-low Breast cancer estrogen receptor Trastuzumab deruxtecan
下载PDF
Estrogen restores disordered lipid metabolism in visceral fat of prediabetic mice
6
作者 Su-Huan Liu Zhao-Shui Shangguan +3 位作者 Paiziliya Maitiaximu Zhi-Peng Li Xin-Xin Chen Can-Dong Li 《World Journal of Diabetes》 SCIE 2024年第5期988-1000,共13页
BACKGROUND Visceral obesity is increasingly prevalent among adolescents and young adults and is commonly recognized as a risk factor for type 2 diabetes.Estrogen[17β-estradiol(E2)]is known to offer protection against... BACKGROUND Visceral obesity is increasingly prevalent among adolescents and young adults and is commonly recognized as a risk factor for type 2 diabetes.Estrogen[17β-estradiol(E2)]is known to offer protection against obesity via diverse me-chanisms,while its specific effects on visceral adipose tissue(VAT)remain to be fully elucidated.AIM To investigate the impact of E2 on the gene expression profile within VAT of a mouse model of prediabetes.METHODS Metabolic parameters were collected,encompassing body weight,weights of visceral and subcutaneous adipose tissues(VAT and SAT),random blood glucose levels,glucose tolerance,insulin tolerance,and overall body composition.The gene expression profiles of VAT were quantified utilizing the Whole Mouse Genome Oligo Microarray and subsequently analyzed through Agilent Feature Extraction software.Functional and pathway analyses were conducted employing Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses,respectively.RESULTS Feeding a high-fat diet(HFD)moderately increased the weights of both VAT and SAT,but this increase was mitigated by the protective effect of endogenous E2.Conversely,ovariectomy(OVX)led to a significant increase in VAT weight and the VAT/SAT weight ratio,and this increase was also reversed with E2 treatment.Notably,OVX diminished the expression of genes involved in lipid metabolism compared to HFD feeding alone,signaling a widespread reduction in lipid metabolic activity,which was completely counteracted by E2 adminis-tration.This study provides a comprehensive insight into E2's local and direct protective effects against visceral adiposity in VAT at the gene level.CONCLUSION In conclusion,the present study demonstrated that the HFD-induced over-nutritional challenge disrupted the gene expression profile of visceral fat,leading to a universally decreased lipid metabolic status in E2 deficient mice.E2 treatment effectively reversed this condition,shedding light on the mechanistic role and therapeutic potential of E2 in combating visceral obesity. 展开更多
关键词 estrogen Obesity Visceral adiposity Energy metabolism Type 2 diabetes
下载PDF
乳腺癌MRI征像与人类表皮生长因子受体2、ER、PR表达的相关性
7
作者 高洋 王鹏飞 +1 位作者 姚雷 丁建峰 《中国计划生育学杂志》 2024年第4期948-952,共5页
目的:探索雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(Her2)表达与乳腺癌磁共振成像(MRI)征像的相关性。方法:回顾性分析2021年1月-2022年12月于本院行乳腺癌手术患者125例临床资料,均于月经后1~2周行MRI检查,由2名专业副主... 目的:探索雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(Her2)表达与乳腺癌磁共振成像(MRI)征像的相关性。方法:回顾性分析2021年1月-2022年12月于本院行乳腺癌手术患者125例临床资料,均于月经后1~2周行MRI检查,由2名专业副主任医师根据MRI图像对病灶组织进行诊断分析MRI征像,包括肿瘤直径、肿瘤形态、强化方式、肿瘤边缘、早期强化率、时间-信号强度曲线(TIC)。采用免疫组织化学SP法检查肿瘤组织中ER、PR、Her2表达。结果:MRI检查,不同肿瘤直径、边缘、形态和TIC的患者PR阳性表达率存在差异,不同肿瘤形态、TIC的患者ER阳性表达率存在差异(均P<0.05);其余不同MRI征像患者ER、PR、Her2阳性表达率未见差异(P>0.05)。肿瘤边缘与ER、Her2阳性表达均呈负相关性(P<0.05),早期强化方式与Her2阳性表达负相关性(P<0.05),其余MRI征像与ER、PR、Her2阳性表达率无明显相关性(P>0.05)。结论:ER、PR、Her2与乳腺癌MRI征像如肿瘤直径、形态、边缘、强化方式等存在相关性。乳腺癌MRI征像可作为乳腺癌组织病理学变化的初步评估,为临床乳腺癌患者的诊治和预后评估提供参考。 展开更多
关键词 乳腺癌 人类表皮生长因子受体2 雌激素受体 孕激素受体 磁共振成像 相关性
下载PDF
乳腺癌超声征象与雌激素受体、孕激素受体、人类上皮生长因子受体-2表达的相关性研究 被引量:1
8
作者 吴艳辉 杨向蓉 +1 位作者 胡大海 敖春庆 《中国社区医师》 2023年第7期110-112,共3页
目的:探讨乳腺癌超声特征与雌激素受体(ER)、孕激素受体(PR)、人类上皮生长因子受体-2(CerB-2)表达及预后的相关性。方法:选取2019年8月—2020年8月贵州航天医院收治的63例乳腺癌患者为研究对象,所有患者行常规超声检查与分子生物学相... 目的:探讨乳腺癌超声特征与雌激素受体(ER)、孕激素受体(PR)、人类上皮生长因子受体-2(CerB-2)表达及预后的相关性。方法:选取2019年8月—2020年8月贵州航天医院收治的63例乳腺癌患者为研究对象,所有患者行常规超声检查与分子生物学相关指标检查。结果:63例乳腺癌患者中,ER阳性表达41例(65.08%),PR阳性表达30例(47.62%),CerB-2阳性表达27例(42.86%);ER、PR和CerB-2表达阳性的肿块中,肿块>20 mm与≤20 mm比较,不规则与规则肿块间比较,差异无统计学意义(P>0.05);ER、PR和CerB-2表达阳性的肿块边缘有毛刺征和后方回声衰减发生率更高,差异有统计学意义(P<0.05);ER、PR表达阳性的肿块中,血供、微钙化、腋窝淋巴情况比较,差异无统计学意义(P>0.05);CerB-2表达阳性的肿块更易出现微钙化,血流信号更丰富,也更易发生淋巴结转移,差异有统计学意义(P<0.05)。结论:乳腺癌超声特征与ER、PR、CerB-2的表达存在一定相关性,超声检查可为乳腺癌的术前诊断、治疗及评估预后提供重要依据。 展开更多
关键词 乳腺癌 超声 雌激素受体 孕激素受体 人类上皮生长因子受体-2
下载PDF
乳腺癌原发灶和腋窝转移淋巴结中雌激素受体、孕激素受体、人表皮生长因子受体2及Ki-67表达情况的比较 被引量:1
9
作者 李文炼 刘争进 +2 位作者 朱文静 杨素梅 魏修兴 《癌症进展》 2023年第16期1767-1770,共4页
目的比较乳腺癌原发灶和腋窝转移淋巴结中雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)和Ki-67表达情况。方法收集50例乳腺癌患者的乳腺癌原发灶组织和腋窝转移淋巴结组织,采用免疫组化染色法检测ER、PR、HER2和Ki-67表... 目的比较乳腺癌原发灶和腋窝转移淋巴结中雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)和Ki-67表达情况。方法收集50例乳腺癌患者的乳腺癌原发灶组织和腋窝转移淋巴结组织,采用免疫组化染色法检测ER、PR、HER2和Ki-67表达情况。比较乳腺癌原发灶和腋窝转移淋巴结中ER、PR、HER2和Ki-67表达情况。结果乳腺癌原发灶和腋窝转移淋巴结中ER、PR、HER2阳性率比较,差异均无统计学意义(P﹥0.05)。乳腺癌原发灶中Ki-67高表达率为70%,高于腋窝转移淋巴结的60%,差异有统计学意义(P﹤0.05)。在乳腺癌原发灶和腋窝转移淋巴结中,ER、PR、HER2和Ki-67表达不一致率分别为8%(4/50)、12%(6/50)、6%(3/50)和30%(15/50)。结论乳腺癌原发灶与腋窝转移淋巴结中ER、PR和HER2表达均具有高度一致性,术后病理标本检测原发灶中ER、PR和HER2的表达可为乳腺癌的治疗和预后评估提供依据,但乳腺癌原发灶和腋窝转移淋巴结中Ki-67需同时检测。 展开更多
关键词 乳腺癌 原发灶 腋窝转移淋巴结 雌激素受体 孕激素受体 人表皮生长因子受体2 KI-67 免疫组化染色
下载PDF
不同雌激素浓度对重组人骨形态发生蛋白2干预乳腺癌MCF-7细胞生长和迁移影响的体外研究
10
作者 刘书中 姚思远 +1 位作者 吴昀效 刘勇 《中国实验诊断学》 2023年第6期705-715,共11页
目的探究不同雌激素浓度对rhBMP-2干预下乳腺癌MCF-7细胞增殖、迁移、侵袭和细胞周期的影响。方法本实验根据处理MCF-7细胞的rhBMP-2、noggin(BMP-2拮抗剂)以及不同雌激素浓度将细胞进行分组。采用MTT试验检测不同作用条件下MCF-7细胞... 目的探究不同雌激素浓度对rhBMP-2干预下乳腺癌MCF-7细胞增殖、迁移、侵袭和细胞周期的影响。方法本实验根据处理MCF-7细胞的rhBMP-2、noggin(BMP-2拮抗剂)以及不同雌激素浓度将细胞进行分组。采用MTT试验检测不同作用条件下MCF-7细胞的增殖能力,Transwell迁移试验及侵袭试验评估不同作用条件下细胞迁移及侵袭能力,利用流式细胞仪检测细胞周期并应用qRT-PCR技术对细胞周期蛋白水平进行定量分析。结果较低浓度的雌激素对rhBMP-2干预后的MCF-7细胞增殖有抑制作用,而高浓度的雌激素对rhBMP-2干预后的MCF-7细胞增殖有促进作用。不同浓度的雌激素均可促进rhBMP-2干预后MCF-7细胞的迁移,其中部分浓度具有统计学意义。不同浓度的雌激素对于rhBMP-2干预后MCF-7细胞的侵袭能力有抑制趋势,但均无统计学差异。RhBMP-2和noggin可不同程度影响G1期,不同雌激素浓度对细胞周期并无显著性影响。不同浓度雌激素处理下基因CDK2、CDK4、cyclinD1、cyclinE、p21转录水平有所差异。结论低浓度的雌激素可协同rhBMP-2对乳腺癌MCF-7细胞增殖产生抑制作用,而高浓度雌激素则拮抗了rhBMP-2对MCF-7细胞增殖的抑制作用。在rhBMP-2作用的基础上,雌激素可进一步降低MCF-7细胞的迁移能力,但对侵袭能力作用无明显统计学差异。不同雌激素浓度对细胞周期并没有显著影响,但可能影响多种细胞周期蛋白的表达。 展开更多
关键词 雌激素浓度 重组人骨形态发生蛋白2 乳腺癌 细胞增殖 迁移和侵袭
下载PDF
Estrogen up-regulates MMP2/9 expression in endometrial epithelial cell via VEGF-ERK1/2 pathway 被引量:16
11
作者 Bao Shan Wang Li +1 位作者 Shu-Ying Yang Zhuo-Ri Li 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2013年第10期826-830,共5页
Objective:To study the effect of estrogen on anovulatory dysfunctional uterine bleeding(ADUB).Methods:Primary endometrial epithelial cells of Hainan Lizu female was cultured and hydrolylic activity of gelalinase was d... Objective:To study the effect of estrogen on anovulatory dysfunctional uterine bleeding(ADUB).Methods:Primary endometrial epithelial cells of Hainan Lizu female was cultured and hydrolylic activity of gelalinase was determined by gelatin zymography analysis.Cellular mRNA and protein synthesis was blocked respectively to determine whether the increased expression of MMP-2/9 was induced by estrogen.The expression of VEGF was blocked by siRNA.After treatment with various factors.MMP-9,VEGF,total Erk and phosphorylated Erk expression in primary uterine epithelial cells was detected by Western blotting analysis.Cell MMP-2/9mRNA levels was measured by real-time RT-PCR.Results:The activity and expression of MMP2/9 was inereased in the endometrium of patients with ADUB.Estrogen could up-regulate the expression of VEGF and activate Erk 1/2-Elk1 signal path.After interference by siRNA,ERK1/2 pathway was blocked in cells,and the expression of MMP-2/9 was down-regulated.ERK1/2 specific blocker U0126 blocked ERK phosphorylation,and it could down-regulate the expression of MMP-2/9.Conclusions:The results showed that the estrogen can increase the expression of VEGF,and thus activate ERK1/2 pathway to induce MMP-2/9 expression. 展开更多
关键词 DYSFUNCTIONAL UTERINE BLEEDING Matrix METALLOPROTEINASE 2 and 9 Vascular endothelial growth factor ERK1/2 signal pathway estrogen Primary UTERINE epithelial cells
下载PDF
17β-Estradiol Regulates Cultured Immature Boar Sertoli Cell Proliferation via the cAMP-ERK1/2 Pathway and the Estrogen Receptor β 被引量:13
12
作者 WANG Xian-zhong ZHAO Bo-chuan ZHOU Yu-lan ZHOU Yin-tao MA Kai-ge ZHANG Jia-hua 《Agricultural Sciences in China》 CAS CSCD 2010年第8期1201-1210,共10页
Estrogen plays an important role in regulating Sertoli cell number in the testis. The objective of the study was to identify whether 17β-estradiol affected the proliferation of cultured, immature boar Sertoli cells v... Estrogen plays an important role in regulating Sertoli cell number in the testis. The objective of the study was to identify whether 17β-estradiol affected the proliferation of cultured, immature boar Sertoli cells via the estrogen receptor β (ERβ) and the cAMP-extracellular signal-regulated kinase (ERK1/2) pathway. Low levels (10-10-10-8 mol L-1) of 17β-estradiol increased cell number, but high levels (10-7-10-6 mol L-1) decreased it (P〈0.05). Sertoli cell number began to recover for an additional 24 h in the medium without 17β-estradiol (10-6 mol L-l) (P〉0.05). The effects of 17β-estradiol (10-9 mol L-1) peaked at the first 24 h (P〈0.05). 17β-estradiol activated ERK1/2 from 5 min to 24 h, but the activiy of ERK1/2 began to decrease after 4 h. Both PD98059 and U0126, two ERK inhibitors, blocked cell division (P〈0.05). 17β-estradiol (10-10-10-6 mol L-1) dose-dependently increased cAMP production (P 〈 0.05), and both 17β-estradiol (10-9 mol L-1) and forskolin, which increases cAMP levels, induced cell proliferation and activated ERK1/2 (P〈 0.05). Rp-cAMP, an antagonist of cAMP, blocked this 17β-estradiol activity (P〈 0.05). Two estrogen receptor antagonists, ICI 182780 and ERβ antagonist (ERβAnt), reduced Sertoli cell number, cAMP production and ERK1/2 activation (P〈 0.05), but ERaAnt did not (P〉 0.05). Therefore, 17β- estradiol mainly promotes pig Sertoli cell proliferation via ERβ to induce cAMP production and ERK activation to promote cell proliferation. 展开更多
关键词 17Β-ESTRADIOL Sertoli cell cell proliferation estrogen receptor ERK1/2
下载PDF
Expression and Significance of NF-κB, IL-1β and COX-2 in the Murine Model of Estrogen-dependent Experimental Vulvovaginal Candidiasis 被引量:3
13
作者 Xue-rong CHEN Ya-li LIU Dun-zhen XIAO Jun GAO 《Journal of Reproduction and Contraception》 CAS 2007年第4期253-260,共8页
Objective To investigate the possible role of estrogen in the pathogenesis of vulvovaginal candidiasis(VVC). Methods Estrogen-dependent experimental murine model of C. albicans vaginal infection was established by i... Objective To investigate the possible role of estrogen in the pathogenesis of vulvovaginal candidiasis(VVC). Methods Estrogen-dependent experimental murine model of C. albicans vaginal infection was established by injecting subcutaneously with estradiol benzoate and then 5 × 10^6 stationary-phase C. albicans blastoconidia was inoculated intravaginally to mice (group El), and other 3 groups were set up." estrogen-treated but not infected (group E); estrogen-untreated but infected (group I); normal control (group C). The dynamic change of colony-forming unit (CFU) of cervivovaginal lavage fluid was observed. Vaginal tissues at different time points (d 2, d 4, d 7 and d 14) after inoculation of C. albicans were obtained. In situ hybridization staining was used to detect expression of cyclooxygenase-2 (COX-2) mRNA and expression of nuclear factor-κB (NF-κB) was examined by immuohistochemistry. ELISA was applied to determine the interlenkin-1β (IL-1β) level. Results The constitutional high level expression of COX-2 mRNA in the vaginal tissue of group E was significantly higher than that in group C on d 4 and d 7 (P〈0. 01), and the optical density (OD) in group EI was higher than that in the other 3 groups (P〈0.05). There were higher IL-1β levels in vaginal tissues from d 4 to d 7 postinoculation in group EI and group I than group C (P〈0.01). Furthermore, IL-1β in group EI was markedly elevated on d 4 and d 7 compared with group I (P〈0.01). Compared with group C, the expression of NF-κB in group E was increased obviously on d 4 (P〈0.01), and there was significant difference between group E1 and group I on d 4 and d 7 (P〈0.01). Conclusions In the murine model of estrogen-dependent experimental WC, estrogen promotes the infection establishment by up-regulating expression of COX-2 via activating NF-κB signal pathway, and the high expression of COX-2 promoted by the interaction of IL-1β and NF-κB after infection formation was involved in persistence of infection. 展开更多
关键词 estrogen Candida albicans VAGINITIS COX-2 IL-1Β NF-ΚB
下载PDF
乳腺癌组织中COL11A1表达与ER、PR、HER-2和Ki-67的相关性分析 被引量:3
14
作者 季盼 杨允博 +3 位作者 白茹梦 贺骁 吕君文 缪琛 《临床肿瘤学杂志》 CAS 2023年第12期1004-1007,共4页
目的探讨乳腺癌组织中Ⅺ型胶原α1(COL11A1)表达与雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体-2(HER-2)和Ki-67的关系。方法采用免疫组化EnVision两步法检测18例乳腺纤维腺瘤组织和120例乳腺癌组织(36例原位癌组织、84例浸润... 目的探讨乳腺癌组织中Ⅺ型胶原α1(COL11A1)表达与雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体-2(HER-2)和Ki-67的关系。方法采用免疫组化EnVision两步法检测18例乳腺纤维腺瘤组织和120例乳腺癌组织(36例原位癌组织、84例浸润性癌组织)中COL11A1的表达,同时对乳腺癌组织进行ER、PR、HER-2和Ki-67免疫组化检测,对HER-2(2+)进行荧光原位杂交检测;分析COL11A1表达与乳腺癌临床病理特征和多种免疫标记(ER、PR、HER-2和Ki-67)的关系。结果免疫组化结果显示COL11A1主要表达于乳腺癌细胞中。在纤维腺瘤组织中COL11A1表达呈弱阳性。COL11A1在原位癌中表达高于浸润性乳腺癌(P<0.05)。COL11A1表达与乳腺癌患者的年龄、部位、肿块大小和淋巴结转移无关(P>0.05),而中、高分化组织的COL11A1表达水平高于低分化组织,差异有统计学意义(P<0.05)。进一步分析COL11A1与乳腺癌其他免疫标记间的相关性发现,在Ki-67高表达组织中COL11A1低表达的比例更高,差异有统计学意义(P<0.05),而其他3种标记与COL11A1的表达无关(P>0.05)。结论COL11A1在浸润性乳腺癌中表达较原位癌低,在低分化乳腺癌中表达水平较中高分化更低,且与Ki-67表达有关,提示COL11Al表达在乳腺癌发生发展过程中是动态变化的,为乳腺癌的诊断治疗提供潜在标记物。 展开更多
关键词 乳腺癌 Ⅺ型胶原α1 雌激素受体 孕激素受体 人表皮生长因子受体-2 KI-67
下载PDF
17β-Estradiol Regulates SKP2 Expression in Cultured Immature Boar Sertoli Cells Mainly via Estrogen Receptor β,cAMP-PKA and ERK1/2
15
作者 WANG Xian-zhong ZHU Feng-wei +3 位作者 WANG Yong WANG Yi ZHANG Jiao-jiao ZHANG Jia-hua 《Journal of Integrative Agriculture》 SCIE CAS CSCD 2014年第4期827-836,共10页
Estrogen plays an important role in regulating testicular Sertoli cell number. Furthermore, S-phase kinase-associated protein 2 (SKP2) plays a central role in mammalian cell cycle progression. The objective of this ... Estrogen plays an important role in regulating testicular Sertoli cell number. Furthermore, S-phase kinase-associated protein 2 (SKP2) plays a central role in mammalian cell cycle progression. The objective of this study was to determine whether 17β-estradiol can regulate the expression of SKP2, and the Sertoli cell cycle, via estrogen receptor β (ERβ), the cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) and extracellular signal-regulated kinase (ERK1/2) pathway. When cultured immature boar Sertoli cells were treated with 17β-estradiol, a time-dependent increase in SKP2 mRNA and protein level was observed by real-time PCR and Western blot, and 17β-estradiol activity peaked at 30 min. Treatment with ICI182780 and ERβ antagonist reduced 17β-estradiol-induced expression of SKP2 and proliferating cell nuclear antigen (PCNA), while increasing the protein concentration of p27kip1. However, the effect of ERa antagonist on these parameters was lower than that of ICI 182780 and ERβ. Forskolin had a similar effect as 17β-estradiol on the expression of SKP2, PCNA and p27kip1, Rp-cAMP, H-89 and U0126 treatment reduced 17β-estradiol-induced changes, while H-89 also inhibited ERK1/2 activation. Therefore, 17β-estradiol mainly regulates SKP2 mRNA and protein expression via ERβ-cAMP-PKA and ERK1/2 activation. SKP2 and PCNA expression were positively correlated, while increased SKP2 expression likely resulted in p27kip1 degradation. 展开更多
关键词 17Β-ESTRADIOL Sertoli cell SKP2 estrogen receptor CAMP-PKA ERK1/2
下载PDF
Expression of estrogen receptor alpha,nerve growth factor,interleukin-2,and androgen receptor in the cerebellum of ovariectomized rats following soybean isoflavone treatment
16
作者 Zhengli Chen Chunmei Zhu +2 位作者 Qihui Luo Kangcheng Pan Anchun Cheng 《Neural Regeneration Research》 SCIE CAS CSCD 2009年第12期965-972,共8页
BACKGROUND: Studies have shown that estrogen receptor alpha (ERα), nerve growth factor (NGF), interleukin-2 (IL-2), and androgen receptor (AR) expression in the cerebellum decreases when estrogen levels decr... BACKGROUND: Studies have shown that estrogen receptor alpha (ERα), nerve growth factor (NGF), interleukin-2 (IL-2), and androgen receptor (AR) expression in the cerebellum decreases when estrogen levels decrease in vivo. Soybean isoflavone, a type of non-steroid estrogen with similar molecular structure and function to estradiol, exhibits estrogen-like characteristics. OBJECTIVE: To investigate the effects of various doses of soybean isoflavone on expression of ERa, NGF, IL-2, and AR in the cerebellum of ovariectomized rat, and to determine whether there is a dose-dependent effect.DESIGN, TIME AND SETTING: Controlled trial at the cellular and molecular level. The study was performed at the Experimental Animal Engineering Center, College of Veterinary Medicine, Sichuan Agricultural University from July 2006 to May 2008. MATERIALS: Soybean isoflavone, comprised of daidzin, genistein and isoflavone, was provided by Taiyuan Yuantai Biochemical Industry, China. The ERα, NGF, IL-2, and AR in situ hybridization kit, rabbit anti-rat ERa, NGF, IL-2, and AR monoclonal antibodies, and SABC kit were purchased from Wuhan Boster Biological Technology, China. METHODS: A total of 50 female, Sprague Dawley rats, aged 3 months, were randomly assigned to 5 groups, with 10 animals in each group. With the exception of the sham-operation group (abdominal cavity opening alone), all rats underwent bilateral ovariectomy. At 14 days after surgery, rats in the high-, middle-, and low-dose soybean isoflavone groups were subcutaneously injected with 1.5, 1.0, and 0.5 mg/kg soybean isoflavone, respectively, every 2 days for 6 consecutive weeks. Rats in the sham-operation and ovariectomized groups were subcutaneously injected with absolute alcohol (0.5 mL/kg). MAIN OUTCOME MEASURES: Expression levels and distribution of ERα, NGF, IL-2, and AR in the cerebellum were detected by immunohistochemistry and in situ hybridization. RESULTS: Compared with the sham-operation group, immunoreactive products and hybridization signals of ERa, NGF, IL-2, and AR were significantly decreased in the cerebellar cortex and nuclei of ovariectomized rats (P 〈 0.05 or P 〈 0.01), but increased following soybean isoflavone treatment. In particular, levels of the high-dose soybean isoflavone group were almost restored to levels of the sham-operation group (P 〉 0.05). The immunoreactive products were primarily located in the cytoplasm and neurites, and rarely in the cell membrane and nuclei. However, the hybridization signals were predominantly located in the nuclei, but rarely in the cytoplasm, cell membrane, or neurites. CONCLUSION: Soybean isoflavone upregulated ERα, NGF, IL-2, and AR protein and gene expression in a dose-dependent manner, and played an important role in sustaining and protecting structure and function of cerebellar neurons. Moreover, the similarity of expression patterns of these molecules indicated that they were mutually interactive during the regulation of soybean isoflavone to the cerebellum. 展开更多
关键词 soybean isoflavone estrogen receptor alpha nerve growth factor INTERLEUKIN-2 androgen receptor CEREBELLUM
下载PDF
Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases
17
作者 Priyadarshini Biswal Susmita Behera +4 位作者 Asaranti Kar Dilleswari Pradhan Pradeep Kumar Behera Subrat Burma Chandraprava Mishra 《International Journal of Clinical Medicine》 2015年第12期961-966,共6页
Introduction-Breast cancer is the most common cancer and leading cause of death in women. In India, its incidence is rapidly rising over last few decades. Present study is aimed to study the pattern of expression of h... Introduction-Breast cancer is the most common cancer and leading cause of death in women. In India, its incidence is rapidly rising over last few decades. Present study is aimed to study the pattern of expression of hormonal receptors and Her-2/neu in invasive breast carcinoma and to correlate estrogen receptor (ER), progesterone receptor (PR) and Her-2/neu expressions with various clinicopathological parameters. Material and methods: The present study was carried out in Department of Pathology, S.C.B. Medical College, Cuttack in the year 2013 taking consecutive 100 cases. Routine H&E staining for histological diagnosis and IHC analysis for ER, PR and Her 2/neu was carried out in all 100 cases of breast malignancies. Results: 99% of cases are invasive breast carcinoma, not otherwise specify (IDC-NOS). The age ranges from 23 years to 72 years. Majority of tumors are of grade 2 (70%) followed by grade 3 (30%). ER PR and Her-2/neu expression are seen in 45%, 35% and 30% respectively. Triple negative cases comprise 35%. Higher number of grade 2 tumor shows ER, PR positivity as compared to grade 3 tumors. Her-2/neu expression does not show any significant correlation with age or lymph node status of the patient. Conclusion: ER and PR expression in breast cancers in the current study are found to be comparable to the findings of other authors, but the frequency of HER-2/neu expression is slightly higher. Significant correlation is observed between hormonal receptor status and the grade of the tumor. Inverse relationship is found between Her-2/neu expression and ER, PR receptor status. Her-2/neu expression is increased with size and high grade of tumor. 展开更多
关键词 Breast Carcinoma estrogen RECEPTOR (ER) PROGESTERONE RECEPTOR (PR) HER-2/NEU IMMUNOHISTOCHEMISTRY
下载PDF
LAMP2 is involved in estrogenic deficiency induced spatial memory impairment through autophagy-AB pathway
18
作者 Cai Xiaoxia Lan Zhen +2 位作者 Meng Zhaoyou Zhang Jiqiang Liu Yan 《解剖学杂志》 CAS 2021年第S01期84-84,共1页
LAMP2(lysosome associated membrane glycoprotein 2)is an important autophagy protein but its role in estrogenic regulation on spatial learning and memory remains unclear.In this study,we first infused aromatase(estroge... LAMP2(lysosome associated membrane glycoprotein 2)is an important autophagy protein but its role in estrogenic regulation on spatial learning and memory remains unclear.In this study,we first infused aromatase(estrogen synthase)-specific RNA interference AAV into the hippocampus of mice,label-free quantitative proteomics analysis revealed that LAMP2 was the most significantly upregulated protein.This upregulation was further proved with RT-PCR,WB,IHC in ovariectomy(OVX)mice.Then,LAMP2-overexpressing(oLAMP2)and RNA interference(shLAMP2)virus vectors were injected into the hippocampus of OVX mice,respectively. 展开更多
关键词 LAMP2 estrogen IMPAIRMENT
下载PDF
Dialogue between estrogen receptor and E2F signaling pathways: The transcriptional coregulator RIP140 at the crossroads
19
作者 Marion Lapierre Aurélie Docquier +4 位作者 Audrey Castet-Nicolas Stéphan Jalaguier Catherine Teyssier Patrick Augereau Vincent Cavaillès 《Advances in Bioscience and Biotechnology》 2013年第10期45-54,共10页
Estrogen receptors and E2F transcription factors are the key players of two nuclear signaling pathways which exert a major role in oncogenesis, particularly in the mammary gland. Different levels of dialogue between t... Estrogen receptors and E2F transcription factors are the key players of two nuclear signaling pathways which exert a major role in oncogenesis, particularly in the mammary gland. Different levels of dialogue between these two pathways have been deciphered and deregulation of the E2F pathway has been shown to impact the response of breast cancer cells to endocrine therapies. The present review focuses on the transcriptional coregulator RIP140/NRIP1 which is involved in several regulatory feed-back loops and inhibitory cross-talks between different nuclear signaling pathways. RIP140 regulates the transactivation potential of estrogen receptors and E2Fs and is also a direct transcriptional target of these transcription factors. Published data highlight the complex regulation of RIP140 expression at the transcriptional level and its potential role in transcription cross-talks. Indeed, a subtle regulation of RIP140 expression levels has important consequences on other transcription networks targeted by this coregulator. Another level of regulation implies titration mechanisms by which activation of a pathway leads to sequestration of the RIP140 protein and thus impinges other gene regulatory circuitries. Altogether, RIP140 occupies a place of choice in the dialogue between nuclear receptors and E2Fs, which could be highly relevant in various human pathologies such as cancer or metabolic diseases. 展开更多
关键词 RIP140 E2F Transcription Factors estrogen Receptors Gene Expression Cell Proliferation Breast Cancer ENDOCRINE THERAPIES
下载PDF
TP53INP1和RAI2在三阴性乳腺癌中的表达及与患者预后的关系
20
作者 逄宗欣 孙萱 +1 位作者 梁庆娜 张玲 《医学临床研究》 CAS 2023年第10期1500-1503,共4页
【目的】探讨三阴性乳腺癌(TNBC)组织中TP53INP1、RAI2的表达水平及与患者临床病理特征和预后的关系。【方法】检测168例TNBC患者癌组织及癌旁组织中的TP53INP1和RAI2表达水平,分析其与患者的临床病理特征及预后的关系。【结果】TNBC患... 【目的】探讨三阴性乳腺癌(TNBC)组织中TP53INP1、RAI2的表达水平及与患者临床病理特征和预后的关系。【方法】检测168例TNBC患者癌组织及癌旁组织中的TP53INP1和RAI2表达水平,分析其与患者的临床病理特征及预后的关系。【结果】TNBC患者癌组织中的TP53INP1、RAI2的阳性率分别为23.21%(39/168)和32.74%(55/168),显著低于癌旁组织的53.57%(90/168)和58.93%(99/168)(P<0.05)。TNBC患者的TP53INP1的表达水平与淋巴结转移、病理分期及TMN分期相关(P<0.05),RAI2的表达水平与淋巴结转移、病理分期相关(P<0.05)。单因素分析结果显示,淋巴转移、TNM分期、TP53INP1表达及RAI2表达是影响患者总生存率和无病生存率的危险因素。无淋巴转移、TNM分期Ⅰ~Ⅱ期、TP53INP1高表达、RAI2高表达的5年无病生存率和5年总生存率均显著高于相对应特征患者,且差异具有统计学意义(P<0.05)。Cox风险回归模型分析显示,TP53INP1、RAI2的表达及淋巴转移均是影响患者无病生存期的独立预后因素。【结论】TP53INP1、RAI2的表达水平与TNBC的发生、发展及预后不良密切相关,TP53INP1、RAI2的高表达可能提示预后良好。 展开更多
关键词 乳腺肿瘤/病理学 受体 erbB-2 雌激素类 孕酮 预后
下载PDF
上一页 1 2 35 下一页 到第
使用帮助 返回顶部